Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders

Huntington's disease is a rare autosomal dominant disorder presenting with chorea, rigidity, hypo-/akinesia, cognitive decline, and psychiatric disturbances. Numerous risk factors have been defined in the onset of this disease. However, the number of CAG repeats in the genes are the most crucial factor rendering patients susceptible to the disease. Studies have shown significant differences in onset and disease presentation among the sexes, which prompts analysis of the impact of different sexes on disease etiology and progression. This article therefore discusses the evidence-based role of sex in aspects of symptomatology, pathogenesis, biomarkers, progression, and prognosis of Huntington's disease, with a secondary review of sex-linked differences in Alzheimer's and Parkinson's disease.

Central centrifugal cicatricial alopecia: a deeper insight into the disease

Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia of multifactorial etiology that presents on the vertex as patchy areas of hair loss, spreading centrifugally over the scalp. It most commonly affects women of African descent, but cases among other ethnicities have also been reported. CCCA typically starts with thinning and breaking of the hair as the first sign of presentation, which eventually progresses to hair loss over the central part of the scalp, spreading symmetrically outwards to involve a larger area. Currently, there is no definitive cure for the disease; however, multiple management options are available, which should aim to be tailored to the individual patient. Owing to its cosmetic outcomes, the quality of life (QoL) of patients with central centrifugal cicatricial alopecia is also disturbed, as patients may face psychological and social stress due to their permanent hair loss. This article focuses on various aspects of the pathogenesis, clinical trials, quality of life, barriers faced by patients, and treatment of central centrifugal cicatricial alopecia.

Life of an amputee: predictors of quality of life after lower limb amputation

Lower limb amputations (LLA) have a significant impact on global morbidity. Approximately 2 million people are living with lower limb amputation in the United States and this figure is expected to rise. LLA lead to physical disabilities and can cause restriction in functionalities in the everyday life of amputees. Patients lose their independence, which can be very debilitating and eventually causes physical, behavioral, and psychical changes. These changes after amputations should be properly addressed and must be incorporated into rehabilitation to improve and regain better adjustment to life among amputees. This article focuses on determining various factors and their effect on quality of life after lower limb amputations.

Machine-Based Algorithm: A Revolution We Need For Early Sepsis Diagnosis In Hospitals

Dear Editor, Sepsis is a life-threatening medical emergency and one of the fundamental causes of early mortality within hospitals. WHO report of 2020 shows that nearly 11 million people worldwide die from sepsis yearly (1). It commonly affects neonates and children; however, pregnant women, the elderly, cancer patients, and bed-bound individuals are particularly at high risk of developing sepsis as well due to the immunosuppressant state of their condition. Sepsis is a clinical diagnosis; thus majorly depends upon a multitude of symptoms, clinical examinations, baseline investigations, and the expertise of the clinicians. Unfortunately, all these methods are highly non-specific, making the diagnosis difficult. Owing to its high mortality, the key to survival lies in the timely initiation of the therapy. Therefore, sepsis requires early diagnosis to help save the life of an affected individual. In this search, multiple systems and methods have been developed previously and used in various hospitals. It includes evaluating by SIRS criteria, detecting the levels of pro-inflammatory markers in the serum, and by newer techniques like diagnosing using electrochemical sensors like PCT (procalcitonin), optical and fluorometric sensors, and microfluidic sensors. These detect different biomarkers in the serum of the patients and thus help in rapid diagnosis. Regardless, the sensitivity and specificity of these systems remain low. ---Continue

Combating psychological distress with psychedelics in cancer patients

Cancer is the leading cause of death worldwide and being diagnosed with cancer can be the source of severe pain and emotional distress to patients. It is not uncommon to find symptoms of depression, anxiety, hopelessness, loss of will to live, and meaning of life. Mitchell et al, found that the symptoms of depression and anxiety are present among 30-40% of hospitalized cancer patients, and 70-90% of cancer patients experience significant pain 1. These symptoms are found to have further debilitating effects on patients which include, non-compliance to medications, decreased quality of life and social functioning, suicidal thoughts, and poor progression and outcomes of the disease. ---Continue